{"url_path":"/sec/roiv/8-k/2026-05-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001635088-26-000060-index.html","accession_number":"0001635088-26-000060","cik":"0001635088","ticker":"ROIV","issuer_name":"Roivant Sciences Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001635088-26-000060-index.html","primary_entity_key":"0001635088","primary_entity_name":"Roivant Sciences Ltd."},"word_count":79,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits.\n\n(d)Exhibits.\n\nExhibit No.Description of Exhibit\n\n[99.1](q4fy2025roivantearningsrel.htm)\nRoivant Science Ltd. Press Release, dated May 20, 2026\n\n104Cover Page Interactive Data File (embedded with Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nROIVANT SCIENCES LTD.\n\nBy: /s/ Keyur Parekh\n\nName: Keyur Parekh\n\nTitle: Authorized Signatory\n\nDated: May 20, 2026"}